Up-regulation of Micro-RNA765 in Human Failing Hearts is Associated with Post-transcriptional Regulation of Protein Phosphatase Inhibitor-1 and Depressed Contractility
Overview
Authors
Affiliations
Aims: Impaired sarcoplasmic reticulum (SR) Ca(2+) cycling and depressed contractility, a hallmark of human and experimental heart failure, has been partially attributed to increased protein phosphatase 1 (PP-1) activity, associated with down-regulation of its endogenous inhibitor-1. The levels and activity of inhibitor-1 are reduced in failing hearts, contributing to dephosphorylation and inactivation of key calcium cycling proteins. Therefore, we investigated the mechanisms that mediate decreases in inhibitor-1 by post-transcriptional modification.
Methods And Results: Bioinformatics revealed that 17 human microRNAs may serve as modulators of inhibitor-1. However, real-time PCR analysis identified only one of these microRNAs, miR-765, as being increased in human failing hearts concomitant with decreased inhibitor-1 levels. Expression of miR-765 in HEK293 cells or mouse ventricular myocytes confirmed suppression of inhibitor-1 levels through binding of this miR-765 to the 3'-untranslated region of inhibitor-1 mRNA. To determine the functional significance of miR-765 in Ca(2+) cycling, pri-miR-765 as well as a non-translated nucleotide sequence (miR-Ctrl) were expressed in adult mouse ventricular myocytes. The inhibitor-1 expression levels were decreased, accompanied by enhanced PP-1 activity in the miR-765 cardiomyocytes, and these reflected depressed contractile mechanics and Ca(2+) transients, compared with the miR-Ctrl group. The depressive effects were associated with decreases in the phosphorylation of phospholamban and SR Ca(2+) load. These miR-765 negative inotropic effects were abrogated in inhibitor-1-deficient cardiomyocytes, suggesting its apparent specificity for inhibitor-1.
Conclusions: miR-765 levels are increased in human failing hearts. Such increases may contribute to depressed cardiac function through reduced inhibitor-1 expression and enhanced PP-1 activity, associated with reduced SR Ca(2+) load.
Yuan M, Jia H, Zhao B, Zhang C, Zuo X Open Med (Wars). 2023; 18(1):20230681.
PMID: 37197359 PMC: 10183725. DOI: 10.1515/med-2023-0681.
The roles and mechanisms of epigenetic regulation in pathological myocardial remodeling.
Zhao K, Mao Y, Li Y, Yang C, Wang K, Zhang J Front Cardiovasc Med. 2022; 9:952949.
PMID: 36093141 PMC: 9458904. DOI: 10.3389/fcvm.2022.952949.
Stress-driven cardiac calcium mishandling via a kinase-to-kinase crosstalk.
McKee C, Bare D, Ai X Pflugers Arch. 2021; 473(3):363-375.
PMID: 33590296 PMC: 7940337. DOI: 10.1007/s00424-021-02533-2.
Zhang Y, Wang G, Ma L, Wang C, Wang L, Guo Y Am J Transl Res. 2019; 11(11):7027-7034.
PMID: 31814906 PMC: 6895521.
Gergs U, Trapp T, Bushnaq H, Simm A, Silber R, Neumann J Adv Med. 2019; 2019:2675972.
PMID: 30719459 PMC: 6334353. DOI: 10.1155/2019/2675972.